Uncategorized

AstraZeneca, GSK intensify China ties with Sino Biopharm deals

Published

on

The U.K. drugmakers added to a series of recent tie-ups with Chinese counterparts amid broader scrutiny of such transactions in the U.S.

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version